No Data
No Data
Voyager Therapeutics Appoints Nathan Jorgensen as CFO
Express News | Vor Biopharma Inc - Board Designated Robert Ang as Company's Interim Principal Financial Officer
Express News | Vor Biopharma Inc - on June 4, 2024, Nathan Jorgensen Notified Co of His Resignation as Chief Financial Officer of Company, Effective as of June 21
Vor Biopharma(VOR.US) Officer Sells US$20,356.55 in Common Stock
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Buy Rating Affirmed for Vor Biopharma Amid Promising Clinical Trials and Market Potential Expansion
No Data